Peptron

087010.KQ

74.31 USD

-7.49

-9.16%

Overview

Last close

74.31 usd

Market cap

1.14B usd

52 week high

93.90 usd

52 week low

5.85 usd

Target price

25.08 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

974.7893

Price/Book Value

113.2901

Enterprise Value

1.74B usd

EV/Revenue

1006.5117

EV/EBITDA

-17.5233

Key financials

Revenue TTM

4.16M usd

Gross Profit TTM

3.20M usd

EBITDA TTM

-7.69M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

41.87B usd

Net debt

N/A usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.